Seetha Shankaran

TL;DR: Differences in hospital practices regarding the initiation of active treatment in infants born at 22, 23, or 24 weeks of gestation explain some of the between-hospital variation in survival and survival without impairment among such patients.

TL;DR: Accurate identification of prenatal drug exposure is improved withGC/MS confirmation and when the meconium assay is coupled with a maternal hospital interview, however, the use of GC/MS may have different implications for research than for public policy.

TL;DR: In the largest at-risk sample observed longitudinally to date, infant prenatal exposure to cocaine and to opiates was not associated with mental, motor, or behavioral deficits after controlling for birth weight and environmental risks.

TL;DR: Central and autonomic nervous system symptoms were more frequent in the exposed cohort and persisted in an adjusted analysis, suggesting a true cocaine effect on newborn infants from birth through hospital discharge.

TL;DR: The CoolCap trial showed a borderline overall effect on death and disability at 18 months of age, but significant improvement in a large subset of infants with less severe electroencephalographic changes as discussed by the authors.